The dream of a pharmaceutical powerhouse, License in and Fast follow are just the starting point

On May 22, China's "father of hepatobiliary surgery" Wu Mengchao and "father of hybrid rice" Yuan Longping passed away one after another on the same day, triggering grief and mourning across the country.

People eat grains, they are born, old, sick, and die.

How to realize the dream of a pharmaceutical powerhouse? I am afraid that it is the only way to go from imitation to creation.

Although the current domestic innovation drug research and development is unprecedentedly prosperous under the promotion of policies and capital, and the listing of new drugs has followed one after another, it is still necessary to realize that my country is not a "pharmaceutical power" and the rise of the pharmaceutical industry is not achieved overnight.

The positive significance of License in is naturally beyond doubt.

In other words, License in and fast follow only solve the food and clothing problem of our goal of becoming a "pharmaceutical power".

At the national policy level, high-level innovation is also being rationally guided.

Dripping water and stone piercing is not a day's work, and the yield per mu is not instantaneous.

In short, innovation is not only a country's development strategy, but also the foundation of a company's survival.

It is gratifying that we are already on the road of innovation, and the results of global originality are gradually showing.